Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing
Brian Jermain, Patrick O. Hanafin, Yanguang Cao, A. Lifschitz, Carlos Lanusse, Gauri G. Rao
Topics & Concepts
IvermectinPharmacokineticsPharmacologyPopulationOral administrationLungChemistryMedicineBiologyInternal medicineVeterinary medicineEnvironmental healthParasitic Diseases Research and TreatmentParasites and Host InteractionsHelminth infection and control